ALVO vs IMCR: stock comparison and AI forecast
Alvotech (ALVO) and Immunocore Holdings Plc (IMCR) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ALVO Alvotech
- Price
- $4.65 +39.2% · 6M
- Market Cap
- $1.66B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
- NO CURRENT FORECAST
IMCR Immunocore Holdings Plc
- Price
- $30.03 +4.1% · 6M
- Market Cap
- $1.55B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- ALVO and IMCR have similar market capitalizations ($1.66B and $1.55B).
- Over the last six months ALVO returned +39.2% and IMCR +4.1%.
- IMCR turns -4.2% of its revenue into net income, against -13.3% for ALVO.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ALVO | IMCR |
|---|---|---|
| Market Cap | $1.66B | $1.55B |
| P/B Ratio | – | 3.68x |
| EPS | $-0.89 | $-0.53 |
| Book Value/Share | – | $8.15 |
| Revenue/Share | $4.53 | $8.36 |
| FCF/Share | $-1.43 | $-0.80 |
Profitability & Margins
| Metric | ALVO | IMCR |
|---|---|---|
| ROE | – | -4.3% |
| ROA | -14.5% | -1.6% |
| ROIC | 18.6% | -2.5% |
| Gross Margin | 61.3% | 99.0% |
| Operating Margin | 13.6% | -5.2% |
| Net Margin | -13.3% | -4.2% |
| EBT Margin | -7.8% | -0.6% |
| Tax Rate | -70.1% | -561.6% |
Financial Health
| Metric | ALVO | IMCR |
|---|---|---|
| Current Ratio | 1.89x | 4.47x |
| Quick Ratio | 1.16x | 4.44x |
| D/E Ratio | – | 1.67x |
| Financial Leverage | – | 2.67x |
| Interest Coverage | – | -1.0x |
| Working Capital | $270M | $816M |
Cash Flow
| Metric | ALVO | IMCR |
|---|---|---|
| Operating Cash Flow | -$345M | -$35M |
| Free Cash Flow | -$510M | -$41M |
| Capital Spending | -$165M | -$6M |
| OCF Growth YoY | – | -204.1% |
| FCF Growth YoY | – | -244.7% |
| FCF/Sales | -31.5% | -9.6% |
| CapEx/Sales | 10.2% | 1.4% |
Operational Efficiency
| Metric | ALVO | IMCR |
|---|---|---|
| Asset Turnover | 1.09x | 0.38x |
| Inventory Turnover | 2.8x | 0.6x |
| Fixed Assets Turnover | 4.5x | 33.5x |
| Days Inventory | 128 days | 661 days |
| Payables Period | 74 days | 2232 days |
Income Statement
| Metric | ALVO | IMCR |
|---|---|---|
| Total Revenue | $1.62B | $431M |
| Operating Income | $220M | -$23M |
| Net Income | -$216M | -$18M |
| R&D Expense | $546M | $284M |
| SG&A Expense | – | $164M |
| Cost of Goods Sold | $625M | $4M |
Dividend & Shareholder Information
| Metric | ALVO | IMCR |
|---|---|---|
| Shares Outstanding | 357M | 52M |
ALVO vs IMCR: stock comparison and AI forecast
Which is bigger, ALVO or IMCR?
ALVO and IMCR have similar market capitalizations ($1.66B and $1.55B).
Which stock performed better over the last six months, ALVO or IMCR?
Over the last six months ALVO returned +39.2% and IMCR +4.1%.
Which one does Intratio's AI model rank higher, ALVO or IMCR?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.